Say your doctor has just suggested esketamine. You nod, write down the word, and walk out to the parking lot realizing you have no idea where you would actually go to get it, or whether your insurance will pay.
That is a very normal place to be. Among 443 Midwest adults in our commissioned survey, Spravato, the brand name of an esketamine nasal spray, was unknown to 73 percent, and only 6 percent knew what it was. Very few people arrive at this step with a map. This guide is one, written for people with employer-sponsored or other commercial insurance, wherever they live.
First, why "in-network" matters so much
Esketamine can only be given at a healthcare site certified under a federal safety program, called a REMS. So your choice is not which pharmacy to use, but which certified center to visit, repeatedly, especially in the early weeks. If that center is outside your plan's network, costs can climb fast.
Coverage is clearly on people's minds. Eighty-five percent of our respondents put insurance among their two main provider priorities, and 65 percent said coverage would settle, or heavily shape, whether they tried the treatment. Both numbers describe the entire sample and come from the validated final survey data. The final data also breaks out a commercial-insurance group of 173 respondents, and coverage weighed just as heavily there: 67 percent called it deciding or big. The rest of this guide is practical, not statistical.
Step 1: Build a list of certified centers
The manufacturer of Spravato maintains an online locator of certified treatment centers. Search by your ZIP code and note every location within a drive you could realistically make several times a week at first. Include psychiatry practices, dedicated interventional psychiatry clinics, and health-system outpatient sites.
Also ask your doctor where they send patients. A referral from someone who knows the local options can save you a lot of calls. Most people in our survey would lean on that relationship anyway: 56 percent would start with their primary care doctor.
Step 2: Cross-check your insurer's directory
Log into your insurer's member portal and search its provider directory for each center on your list. Look for the facility itself and, if possible, the prescribing clinician.
Be aware that insurer directories are sometimes out of date. Treat a directory listing as a lead, not a promise.
Step 3: Call the insurer
Use the member services number on your card. Ask:
- Is esketamine (Spravato) covered under my plan?
- Is prior authorization required, and what are the criteria?
- Is it billed through my medical benefit or through pharmacy?
- Are these specific centers in network for this service?
- What will my cost sharing be for the drug and for the monitoring visit?
- Where am I on my deductible and out-of-pocket maximum this year?
Note the date, the representative's name, and the call's reference number.
Step 4: Call the centers
Now confirm from the other side. Ask each center:
- Do you accept my specific plan for esketamine treatment?
- Which side, you or my doctor, sends the prior authorization, and what timeline should I expect?
- Do you bill the drug under the medical benefit, or do you work through a specialty pharmacy?
- What does a typical first month look like in terms of visits?
- How long is each visit, including monitoring time?
- Do you offer early morning, evening, or weekend appointments?
- Do you need a referral from my doctor, and what records should they send?
A center that answers these clearly and patiently is telling you something about how it will treat you as a patient.
Step 5: Plan the logistics
Distance was the second most common priority in our survey, chosen by 44 percent. With esketamine, distance compounds, because you cannot drive yourself home after a session. For each finalist center, work out:
- Who can drive you on treatment days, and whether a rideshare is realistic.
- How much time each visit will take door to door.
- Whether you will need time off work. If you are eligible, job-protected leave laws such as FMLA may allow intermittent leave for a serious health condition. Your HR team can explain the options confidentially.
Most people in our survey preferred care with a physical location involved. In-person clinic care was the top pick at 44 percent, and clinic-then-home was chosen by 23 percent. For esketamine, in-person is not optional, so choose a site you can live with.
Step 6: Check cost support
Through its patient support program, the manufacturer has helped some commercially insured patients with costs. Ask the treatment center or visit the program's website to check eligibility. These programs typically exclude people on government insurance such as Medicare or Medicaid.
Step 7: Start the paperwork
Your doctor or the treatment center will usually submit the prior authorization. Help it along by giving them a list of each antidepressant you have been on, with the dose, the approximate dates, and why you stopped. Insurers frequently want exactly that.
If you are denied, ask why. Many denials are about missing documentation and can be resolved with more records or a doctor-to-reviewer call. An internal appeal is also open to you, and many cases qualify for an independent external review.
What to watch out for
Some clinics advertise "ketamine therapy" without being certified esketamine centers. They may offer IV ketamine infusions or at-home ketamine, which are off-label for depression and often cash-pay. That is a different treatment with different oversight. If a clinic is vague about whether it provides FDA-approved esketamine or off-label ketamine, ask directly. This Spravato overview explains what the approved treatment involves.
And remember that the decision about whether esketamine suits you belongs with the clinician who treats you.
Struggling badly while you sort all this out? Do not wait. Phone or text 988 whenever you need to; the Suicide and Crisis Lifeline charges nothing, whatever plan you carry, and veterans can press 1.
Methodology
The figures cited come from a survey we ran on Pollfish's consumer panel. It drew answers from 443 people, all 18 to 64, across Missouri, Kansas, Illinois, Iowa, Nebraska, Oklahoma, Indiana, Ohio, Wisconsin, and Minnesota; it closed June 23, 2026. Results are whole-sample, the commercial-insurance figure excepted. Every number comes from Pollfish's validated final data. The publisher commissioned and financed the survey. This guide is general information and not medical, legal, or insurance advice.